FDA clears Siemens fluoroscopy, radiography systems

Keith Moore | | Health Imaging | Diagnostic Imaging
Siemens Healthcare Luminos Agile Fluoroscopy/Radiography system has received 510(k) clearance from the FDA and is now commercially available in the U.S.

The Luminos Agile is a patient-side controlled system with flat-panel detector technology, a height-adjustable table and dual-use capability for fluoroscopy and radiography.

The system’s flat-panel detector enables users to view objects without repositioning or changing the field of view, reducing overall fluoroscopy time and dose, while the horizontal and vertical transfer positions accommodate a wide range of patients, including children and those with mobility challenges. In addition, the motorized tower and synchronized table allow for improved radiography workflow and increased patient throughput, according to Malvern, Pa.-based Siemens.

Keith Moore

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.